Cytek Biosciences (CTKB) Faced Challenges from NIH Funding Reductions
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2025 investor letter.
Cytek Biosciences Inc. (CTKB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hillhouse Capital Management Lei Zhang | 6,657,030 | $26,694,690 | 0.75% | |
| 2. | Topline Capital Collin Mcbirney | 1,470,775 | $5,897,808 | +522% | 1.35% |
| 3. | Renaissance Technologies Jim Simons | 687,600 | $2,757,276 | +49% | 0% |
| 4. | AQR Capital Management Cliff Asness | 653,277 | $2,619,640 | +395% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 602,517 | $2,416,093 | +200% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.78 | 35,000 | $97,300.00 | 55,746 | 2025-06-02 | Filing | |
| $12.27 | 241,727 | $2,964,999.21 | 13,381,054 | 2022-03-15 | Filing | |
| $12.35 | 342,143 | $4,223,926.41 | 13,139,327 | 2022-03-14 | Filing | |
| $12.77 | 337,492 | $4,309,334.10 | 12,797,184 | 2022-03-11 | Filing | |
| $12.95 | 256,992 | $3,327,583.81 | 12,459,692 | 2022-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.87 | 20,000 | $117,400.00 | 5,988,502 | 2024-04-19 | Filing | |
| $7.01 | 400 | $2,804.00 | 6,008,502 | 2024-04-09 | Filing | |
| $7.00 | 1,500 | $10,500.00 | 6,008,902 | 2024-04-09 | Filing | |
| $6.71 | 20,000 | $134,200.00 | 6,010,402 | 2024-03-19 | Filing | |
| $6.77 | 20,000 | $135,400.00 | 6,030,402 | 2024-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,069,282 | $72,457,819 | 0% | |
| 2. | 9,622,008 | $38,584,252 | 0% | |
| 3. | 7,463,967 | $29,930,508 | 0.9% | |
| 4. | 4,382,174 | $17,572,518 | 0% | |
| 5. | 2,853,809 | $11,443,706 | 0% |
News See All
Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo System
Cytek Biosciences, Inc. (NASDAQ:CTKB) has announced the launch of its latest innovation, the Cytek Aurora Evo system, marking a significant leap forward in flow cytometry technology.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I would like to welcome everyone to the Cytek Biosciences First Quarter 2025 Earnings Conference Call.
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds
Shares priced under $5, commonly referred to as penny stocks, are a tempting bet for investors chasing big returns with minimal upfront investment.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by, and good day, everyone. My name is RG, and I will be your conference operator today.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I'd like to welcome everyone to the Cytek Biosciences' Third Quarter 2024 Earnings Conference Call.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Luella, and I will be your conference operator today.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Liz, and I'll be your conference operator today.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Cytek Biosciences Fourth Quarter 2023 Earnings Conference Call.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Cytek Biosciences Third Quarter 2023 Earnings Conference Call.
Billionaire Hedge Funds
